Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Free Tissue Flaps | 10 | 2024 | 63 | 3.180 |
Why?
|
| Head and Neck Neoplasms | 9 | 2025 | 288 | 2.490 |
Why?
|
| Surgical Flaps | 5 | 2023 | 110 | 1.440 |
Why?
|
| Mandibular Reconstruction | 3 | 2024 | 15 | 1.330 |
Why?
|
| Mandible | 2 | 2024 | 25 | 0.990 |
Why?
|
| Osteoradionecrosis | 1 | 2024 | 6 | 0.930 |
Why?
|
| Mandibular Diseases | 1 | 2024 | 11 | 0.930 |
Why?
|
| Length of Stay | 2 | 2024 | 663 | 0.870 |
Why?
|
| Scapula | 1 | 2023 | 16 | 0.840 |
Why?
|
| Retrospective Studies | 21 | 2025 | 6607 | 0.690 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 436 | 0.690 |
Why?
|
| Temporal Arteries | 2 | 2015 | 16 | 0.560 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 619 | 0.550 |
Why?
|
| Middle Aged | 17 | 2025 | 13028 | 0.520 |
Why?
|
| Fibula | 4 | 2024 | 23 | 0.450 |
Why?
|
| Ear Canal | 1 | 2014 | 13 | 0.430 |
Why?
|
| Time-to-Treatment | 2 | 2025 | 78 | 0.430 |
Why?
|
| Equipment Failure | 1 | 2013 | 64 | 0.420 |
Why?
|
| Ear Diseases | 1 | 2014 | 28 | 0.420 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2024 | 649 | 0.410 |
Why?
|
| Aged | 12 | 2025 | 10121 | 0.410 |
Why?
|
| Cochlear Implants | 1 | 2013 | 67 | 0.400 |
Why?
|
| Cochlear Implantation | 1 | 2013 | 81 | 0.390 |
Why?
|
| Treatment Outcome | 10 | 2024 | 5422 | 0.390 |
Why?
|
| Male | 19 | 2025 | 26761 | 0.380 |
Why?
|
| Hearing Loss | 1 | 2013 | 96 | 0.380 |
Why?
|
| Humans | 28 | 2025 | 52483 | 0.350 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2024 | 332 | 0.350 |
Why?
|
| Female | 18 | 2025 | 28171 | 0.350 |
Why?
|
| Nasal Septum | 1 | 2010 | 8 | 0.340 |
Why?
|
| Nose Diseases | 1 | 2010 | 8 | 0.340 |
Why?
|
| Eosinophilia | 1 | 2010 | 36 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 1165 | 0.290 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2025 | 63 | 0.290 |
Why?
|
| Adult | 10 | 2025 | 14161 | 0.290 |
Why?
|
| Postoperative Complications | 6 | 2024 | 1068 | 0.270 |
Why?
|
| Reoperation | 2 | 2021 | 465 | 0.250 |
Why?
|
| Erythrocyte Transfusion | 1 | 2024 | 52 | 0.220 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2024 | 19 | 0.220 |
Why?
|
| Skull | 1 | 2024 | 80 | 0.220 |
Why?
|
| Scalp | 1 | 2024 | 43 | 0.220 |
Why?
|
| Deglutition | 1 | 2024 | 44 | 0.220 |
Why?
|
| Physical Examination | 1 | 2024 | 99 | 0.220 |
Why?
|
| Paranasal Sinuses | 1 | 2023 | 15 | 0.210 |
Why?
|
| Operative Time | 1 | 2023 | 77 | 0.210 |
Why?
|
| Blood Transfusion | 1 | 2024 | 127 | 0.210 |
Why?
|
| Sinusitis | 1 | 2023 | 42 | 0.210 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2023 | 53 | 0.210 |
Why?
|
| Enteral Nutrition | 1 | 2024 | 154 | 0.210 |
Why?
|
| Deglutition Disorders | 1 | 2024 | 79 | 0.200 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 3392 | 0.200 |
Why?
|
| Tramadol | 1 | 2022 | 30 | 0.200 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 891 | 0.190 |
Why?
|
| Intraoperative Care | 1 | 2021 | 51 | 0.190 |
Why?
|
| Hypotension | 1 | 2021 | 62 | 0.180 |
Why?
|
| Vasoconstrictor Agents | 1 | 2021 | 82 | 0.180 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 90 | 0.170 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 112 | 0.170 |
Why?
|
| Acetaminophen | 1 | 2022 | 279 | 0.160 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1229 | 0.160 |
Why?
|
| Arkansas | 1 | 2025 | 2028 | 0.150 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 505 | 0.150 |
Why?
|
| Thrombosis | 1 | 2021 | 253 | 0.150 |
Why?
|
| Risk Factors | 1 | 2024 | 3889 | 0.120 |
Why?
|
| Periosteum | 1 | 2015 | 26 | 0.120 |
Why?
|
| Otologic Surgical Procedures | 1 | 2015 | 37 | 0.120 |
Why?
|
| Adolescent | 4 | 2014 | 6739 | 0.120 |
Why?
|
| Cartilage | 1 | 2014 | 47 | 0.110 |
Why?
|
| Tympanoplasty | 1 | 2014 | 57 | 0.110 |
Why?
|
| Cleft Palate | 1 | 2014 | 79 | 0.100 |
Why?
|
| Head | 2 | 2021 | 70 | 0.090 |
Why?
|
| Neck | 2 | 2021 | 97 | 0.090 |
Why?
|
| Chloride Channels | 1 | 2010 | 26 | 0.090 |
Why?
|
| Nasal Obstruction | 1 | 2010 | 11 | 0.090 |
Why?
|
| Mandibular Neoplasms | 1 | 2010 | 6 | 0.080 |
Why?
|
| Nasal Mucosa | 1 | 2010 | 19 | 0.080 |
Why?
|
| Oral Surgical Procedures | 1 | 2010 | 7 | 0.080 |
Why?
|
| Ablation Techniques | 1 | 2010 | 21 | 0.080 |
Why?
|
| Skull Base Neoplasms | 1 | 2010 | 20 | 0.080 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2010 | 20 | 0.080 |
Why?
|
| Skin Transplantation | 1 | 2010 | 44 | 0.080 |
Why?
|
| Radius | 1 | 2010 | 27 | 0.080 |
Why?
|
| Blood Loss, Surgical | 1 | 2010 | 71 | 0.080 |
Why?
|
| Fibrosis | 1 | 2010 | 196 | 0.080 |
Why?
|
| Endoscopy | 1 | 2010 | 123 | 0.080 |
Why?
|
| Video Recording | 2 | 2024 | 81 | 0.070 |
Why?
|
| Forearm | 2 | 2023 | 32 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2024 | 2481 | 0.070 |
Why?
|
| Young Adult | 2 | 2014 | 4329 | 0.070 |
Why?
|
| Smoking | 1 | 2010 | 520 | 0.060 |
Why?
|
| Child | 3 | 2014 | 7248 | 0.060 |
Why?
|
| Infant | 1 | 2013 | 3733 | 0.060 |
Why?
|
| Fluoroscopy | 1 | 2024 | 50 | 0.050 |
Why?
|
| Facial Bones | 1 | 2023 | 18 | 0.050 |
Why?
|
| Critical Pathways | 1 | 2023 | 35 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 124 | 0.050 |
Why?
|
| Ibuprofen | 1 | 2022 | 22 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 2279 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2022 | 78 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2024 | 639 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 239 | 0.050 |
Why?
|
| Microsurgery | 1 | 2021 | 30 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2024 | 772 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2021 | 68 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 169 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 944 | 0.050 |
Why?
|
| Thrombelastography | 1 | 2021 | 26 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2022 | 136 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 220 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 374 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 721 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 558 | 0.040 |
Why?
|
| Prognosis | 1 | 2024 | 2099 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 590 | 0.030 |
Why?
|
| Temporal Muscle | 1 | 2015 | 3 | 0.030 |
Why?
|
| Dissection | 1 | 2015 | 14 | 0.030 |
Why?
|
| Cadaver | 1 | 2015 | 96 | 0.030 |
Why?
|
| Hearing Tests | 1 | 2014 | 27 | 0.030 |
Why?
|
| Hearing | 1 | 2014 | 63 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2010 | 3 | 0.020 |
Why?
|
| Ion Transport | 1 | 2010 | 15 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2010 | 91 | 0.020 |
Why?
|
| Debridement | 1 | 2010 | 48 | 0.020 |
Why?
|
| Graft Survival | 1 | 2010 | 160 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 199 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2010 | 215 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 4076 | 0.020 |
Why?
|
| Diet | 1 | 2010 | 587 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1884 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 5949 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 13505 | 0.010 |
Why?
|